Middle East & Africa Gene Synthesis Market Size & Outlook

The gene synthesis market in Middle East & Africa is expected to reach a projected revenue of US$ 102.2 million by 2033. A compound annual growth rate of 11.4% is expected of Middle East & Africa gene synthesis market from 2025 to 2033.
Revenue, 2024 (US$M)
$39.1
Forecast, 2033 (US$M)
$102.2
CAGR, 2025 - 2033
11.4%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa gene synthesis market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

MEA gene synthesis market highlights

  • The MEA gene synthesis market generated a revenue of USD 39.1 million in 2024.
  • The market is expected to grow at a CAGR of 11.4% from 2025 to 2033.
  • In terms of segment, pcr-based enzyme synthesis was the largest revenue generating method in 2024.
  • PCR-based Enzyme Synthesis is the most lucrative method segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2025 to 2033.


MEA data book summary

Market revenue in 2024USD 39.1 million
Market revenue in 2033USD 102.2 million
Growth rate11.4% (CAGR from 2025 to 2033)
Largest segmentPcr-based enzyme synthesis
Fastest growing segmentPCR-based Enzyme Synthesis
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationSolid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis
Key market players worldwideGenscript Biotech Corp Class H, Brooks Automation, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies


Other key industry trends

  • In terms of revenue, MEA region accounted for 1.9% of the global gene synthesis market in 2024.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,469.0 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gene Synthesis Market Companies

Name Profile # Employees HQ Website
Bosterbio View profile 11-50 Pleasanton, California, United States, North America https://www.bosterbio.com/
ProMab Biotechnologies Inc View profile 51-100 Richmond, California, United States, North America http://www.promab.com
Integrated DNA Technologies View profile 501-1000 Coralville, Iowa, United States, North America http://idtdna.com
Biomatik Corporation View profile 11-50 Cambridge, Ontario, Canada, North America http://www.biomatik.com
ProteoGenix View profile 11-50 Costa Mesa, California, United States, North America https://www.proteogenix.science
Origene Technologies View profile 501-1000 Rockville, Maryland, United States, North America http://www.origene.com
Brooks Automation View profile 1001-5000 Chelmsford, Massachusetts, United States, North America http://www.brooks.com
Twist Bioscience Corp View profile 919 681 Gateway Boulevard, South San Francisco, CA, United States, 94080 https://www.twistbioscience.com
Genscript Biotech Corp Class H View profile 6937 No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 https://www.genscript.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Middle East & Africa gene synthesis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis market will help companies and investors design strategic landscapes.


Pcr-based enzyme synthesis was the largest segment with a revenue share of 42.2% in 2024. Horizon Databook has segmented the Middle East & Africa gene synthesis market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2021 to 2033.


The Middle East and Africa (MEA) region is anticipated to witness growth in the gene synthesis market due to increasing investments and strategic initiatives from local governments toward development of biotechnological capabilities.

For instance, the Kingdom of Saudi Arabia had a budget of around USD 46 billion for social care and healthcare in 2019, representing tremendous opportunities for investments in medical applications of emerging technologies, such as gene synthesis.

Furthermore, organizations such as SaudiVax are coordinating cell & gene therapy development activities for enhancing access to these therapies in the Middle East and North Africa, which, in turn, can boost the growth prospects for gene synthesis technologies.

Reasons to subscribe to Middle East & Africa gene synthesis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa gene synthesis market databook

  • Our clientele includes a mix of gene synthesis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa gene synthesis market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa gene synthesis market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA gene synthesis market report size, by country, 2021-2033 (US$M)

Middle East & Africa Gene Synthesis Market Share, 2024 & 2033 (US$M)

MEA gene synthesis market report size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online